Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Sulfo-NHS-SS-Biotin: Cleavable Protein Labeling for Purifica
2026-06-29
Sulfo-NHS-SS-Biotin stands apart as a water-soluble, cleavable biotin disulfide N-hydroxysulfosuccinimide ester, enabling fast, reversible labeling of cell surface proteins with high specificity. Its unique disulfide spacer empowers dynamic affinity purification workflows, offering researchers the flexibility to isolate, analyze, and release target proteins under mild conditions.
-
Netrin-1 Modulates Adipogenesis via PPARγ and Wnt/β-catenin
2026-06-29
This study establishes a mechanistic link between adipose-derived Netrin-1 and the regulation of adipogenesis under high-fat diet conditions. By dissecting the interplay between PPARγ inhibition and Wnt/β-catenin signaling activation, the research highlights Netrin-1 as a negative regulator of compensatory adipose remodeling, shaping new perspectives on metabolic disorders and potential therapeutic targets.
-
Genotyping Kit for Target Alleles: Precision in Microbiome-D
2026-06-28
Explore how the Genotyping Kit for target alleles of insects, tissues, fishes and cells accelerates PCR-based genetic analysis in microbiome and barrier function studies. This article uniquely bridges rapid DNA prep with advanced applications in host-microbe interaction research.
-
LY2603618: Chk1 Inhibitor Protocols for DNA Damage Research
2026-06-27
LY2603618 is redefining experimental precision in DNA damage response studies by enabling robust cell cycle arrest and sensitization in cancer models. This article details actionable workflows and troubleshooting strategies to maximize its utility as a Chk1 inhibitor—especially for non-small cell lung cancer and iPSC-based assay platforms.
-
L-Phenylephrine: Optimizing Adrenergic α1A Agonist Workflows
2026-06-26
L-Phenylephrine enables highly selective modeling of adrenergic α1A receptor signaling, unlocking robust cardiac and neural research workflows. This article details experimental protocols, troubleshooting strategies, and key findings that set L-Phenylephrine apart as an advanced tool for dissecting vasoconstrictor and gene regulatory mechanisms.
-
Short-Scale Break-Induced DNA Replication in Mouse Oocytes
2026-06-26
This study uncovers a unique form of short-scale break-induced replication (ssBIR) triggered by double-strand breaks in fully grown mouse oocytes, revealing mechanisms of DNA damage amplification distinct from those in growing oocytes. The findings offer mechanistic insights into oocyte genome stability and highlight how chemical inhibitors—including ddATP—modulate DNA repair dynamics.
-
Mouse Tissue Lysis Kit (K1038): Protocol and Workflow Guide
2026-06-25
The Mouse Tissue Lysis Kit (K1038) is designed to rapidly lyse mouse tissues, enabling direct use of genomic DNA in PCR-based genotyping assays. It streamlines molecular biology workflows by eliminating traditional extraction and purification steps. This kit is intended solely for research use and is not suitable for clinical or diagnostic applications.
-
YM 58483 (BTP2): Advanced SOCE Blockade for Fibrosis and Imm
2026-06-25
Explore how YM 58483 (BTP2), a potent SOCE inhibitor, enables precise modulation of calcium signaling in fibrosis and immune research. This article uniquely examines its assay impact, protocol optimization, and translational potential.
-
Anp32e Drives Renal Fibrosis via TGF-β1/Smad3: Mechanistic I
2026-06-24
This study reveals that Anp32e significantly contributes to renal interstitial fibrosis by upregulating fibrosis-related proteins through activation of the TGF-β1/Smad3 signaling pathway. The findings provide mechanistic clarity on Anp32e’s role in chronic kidney disease progression and underscore the value of TGF-β pathway inhibition as a research approach.
-
Cholesterol Impedes Lipid Nanoparticle Trafficking in Cells
2026-06-23
This study uncovers how elevated cholesterol content in lipid nanoparticles (LNPs) impairs their intracellular trafficking by promoting entrapment in peripheral early endosomes, ultimately reducing the efficiency of nucleic acid delivery. The findings emphasize the need to optimize LNP composition beyond cationic lipid content for improved endosomal escape and delivery performance.
-
Isolation and Pathogenesis of Chlamydia felis in Feline URTD
2026-06-23
This study systematically isolates and characterizes Chlamydia felis from domestic cats, demonstrating its significant role in feline upper respiratory tract disease (URTD) and establishing a comprehensive animal model. The findings clarify C. felis transmission, tissue tropism, and pathogenesis, offering new avenues for vaccine and therapeutic evaluation.
-
Primidone (SKU B2120): Reliable RIPK1 & TRPM3 Inhibition in
2026-06-22
This article provides a scenario-driven, evidence-based guide for deploying Primidone (SKU B2120) in cell viability and neurodegenerative disease assays. Integrating quantitative data and real-world lab challenges, it demonstrates how APExBIO's Primidone ensures reproducible RIPK1 and TRPM3 inhibition, optimizing workflows for ALS and related disease models.
-
Lactobacillus gasseri ATCC33323 Modulates E-cadherin to Amel
2026-06-22
This study demonstrates that Lactobacillus gasseri ATCC33323 alleviates DSS-induced colitis in mice through NR1I3-mediated upregulation of E-cadherin, thereby strengthening the intestinal mucosal barrier. The findings clarify a novel probiotic mechanism with potential translational relevance for inflammatory bowel disease therapy.
-
Octenidine Dihydrochloride: Mechanistic Insights for Antisep
2026-06-21
Explore advanced, mechanistic perspectives on Octenidine dihydrochloride as a research-grade antiseptic. This article offers deep analysis of its molecular action, scientific utility, and unique value for laboratory assay design.
-
LY2228820: Potent p38 MAP Kinase Inhibitor for Research Use
2026-06-20
LY2228820 is a highly selective, ATP-competitive p38 MAP kinase inhibitor with nanomolar potency against p38α and p38β isoforms. Its dual mechanism not only blocks kinase activity but also accelerates dephosphorylation, supporting anti-inflammatory and cancer research. This article provides a dense, citation-backed dossier for experimental and translational scientists.